Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Leukemia

  Free Subscription


19.08.2019

2 Ann Hematol
5 Blood
1 Cancer
1 Genes Chromosomes Cancer
1 Int J Hematol
1 J Clin Oncol
1 J Pediatr Hematol Oncol
1 Leuk Lymphoma
1 Leuk Res
9 Leukemia
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Hematol

  1. NG DB, Schiller G, Ha E
    Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib.
    Ann Hematol. 2019 Aug 13. pii: 10.1007/s00277-019-03780.
    PubMed     Text format    

  2. KIDOGUCHI K, Kojima K, Yokoo M, Kimura S, et al
    BCR-ABL1- and CBFB-MYH11-positive chronic myeloid leukemia presenting with primary blast crisis and marrow fibrosis.
    Ann Hematol. 2019 Aug 10. pii: 10.1007/s00277-019-03779.
    PubMed     Text format    


    Blood

  3. MICHAELIS LC
    Venetoclax in AML: aiming for "just right".
    Blood. 2019;133:3-4.
    PubMed     Text format    

  4. VENDITTI A, Piciocchi A, Candoni A, Melillo L, et al
    GIMEMA AML1310 TRIAL OF RISK-ADAPTED, MRD-DIRECTED THERAPY FOR YOUNG ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA.
    Blood. 2019 Aug 8. pii: blood.2018886960. doi: 10.1182/blood.2018886960.
    PubMed     Text format     Abstract available

  5. ZHU Y, He X, Lin YC, Dong H, et al
    Targeting PRMT1-Mediated FLT3 Methylation Disrupts Maintenance of MLL- rearranged Acute Lymphoblastic Leukemia.
    Blood. 2019 Aug 8. pii: blood.2019002457. doi: 10.1182/blood.2019002457.
    PubMed     Text format     Abstract available

  6. CHEN Y, Chen L, Yu J, Ghia EM, et al
    Cirmtuzumab Blocks Wnt5a/ROR1-Stimulation Of NF-kappaB To Repress Autocrine STAT3-Activation In Chronic Lymphocytic Leukemia.
    Blood. 2019 Aug 13. pii: blood.2019001366. doi: 10.1182/blood.2019001366.
    PubMed     Text format     Abstract available

  7. JANKE LJ, Van Driest SL, Portera MV, Atreya RV, et al
    Hypertension is a modifiable risk-factor for osteonecrosis in acute lymphoblastic leukemia.
    Blood. 2019 Aug 13. pii: blood.2019000006. doi: 10.1182/blood.2019000006.
    PubMed     Text format    


    Cancer

  8. WU J, Chen Y, Hageman L, Francisco L, et al
    Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) report.
    Cancer. 2019 Aug 14. doi: 10.1002/cncr.32443.
    PubMed     Text format     Abstract available


    Genes Chromosomes Cancer

  9. BOHLANDER SK
    Preface to Special Issue: Acute Myeloid Leukemia: Genetics, Stem Cells, Clonal Evolution and New Therapies.
    Genes Chromosomes Cancer. 2019 Aug 13. doi: 10.1002/gcc.22800.
    PubMed     Text format    


    Int J Hematol

  10. HASEGAWA D, Yoshimoto Y, Kimura S, Kumamoto T, et al
    Bortezomib-containing therapy in Japanese children with relapsed acute lymphoblastic leukemia.
    Int J Hematol. 2019 Aug 10. pii: 10.1007/s12185-019-02714.
    PubMed     Text format     Abstract available


    J Clin Oncol

  11. GUERCIO BJ, Zhang S, Ou FS, Venook AP, et al
    Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.
    J Clin Oncol. 2019 Aug 13:JCO1901019. doi: 10.1200/JCO.19.01019.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  12. MANGUM R, Soler-Alfonso C, Birchansky S, Stevens A, et al
    Survival and Neurological Recovery After Prompt Diagnosis and Aggressive Management of Severe Idiopathic Hyperammonemic Encephalopathy in a Patient with Acute Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2019 Aug 12. doi: 10.1097/MPH.0000000000001579.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  13. CORTES J, Huynh L, Mendelson E, Brandt P, et al
    Treatment patterns and deep molecular response in chronic phase - chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study.
    Leuk Lymphoma. 2019 Aug 13:1-10. doi: 10.1080/10428194.2019.1644332.
    PubMed     Text format     Abstract available


    Leuk Res

  14. SHANG J, Chen WM, Liu S, Wang ZH, et al
    CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy.
    Leuk Res. 2019;85:106198.
    PubMed     Text format     Abstract available


    Leukemia

  15. BATALLER A, Montalban-Bravo G, Soltysiak KA, Garcia-Manero G, et al
    The role of TGFbeta in hematopoiesis and myeloid disorders.
    Leukemia. 2019;33:1076-1089.
    PubMed     Text format     Abstract available

  16. BAQUERO P, Dawson A, Mukhopadhyay A, Kuntz EM, et al
    Targeting quiescent leukemic stem cells using second generation autophagy inhibitors.
    Leukemia. 2019;33:981-994.
    PubMed     Text format     Abstract available

  17. DORON B, Abdelhamed S, Butler JT, Hashmi SK, et al
    Transmissible ER stress reconfigures the AML bone marrow compartment.
    Leukemia. 2019;33:918-930.
    PubMed     Text format     Abstract available

  18. ZABORSKY N, Gassner FJ, Hopner JP, Schubert M, et al
    Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.
    Leukemia. 2019;33:957-968.
    PubMed     Text format     Abstract available

  19. PAGANO MA, Tibaldi E, Molino P, Frezzato F, et al
    Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL.
    Leukemia. 2019;33:1148-1160.
    PubMed     Text format     Abstract available

  20. WANG TT, Yang J, Zhang Y, Zhang M, et al
    IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective gamma-chain cytokines, decreases leukemic T-cell viability.
    Leukemia. 2019;33:1243-1255.
    PubMed     Text format     Abstract available

  21. POTTER N, Jones L, Blair H, Strehl S, et al
    Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia.
    Leukemia. 2019;33:893-904.
    PubMed     Text format     Abstract available

  22. POTTER N, Miraki-Moud F, Ermini L, Titley I, et al
    Single cell analysis of clonal architecture in acute myeloid leukaemia.
    Leukemia. 2019;33:1113-1123.
    PubMed     Text format     Abstract available

  23. FALINI B, Spinelli O, Meggendorfer M, Martelli MP, et al
    IDH1-R132 changes vary according to NPM1 and other mutations status in AML.
    Leukemia. 2019;33:1043-1047.
    PubMed     Text format    


    PLoS One

  24. YOSHINARI GH JR, Fassoni AC, Mello LF, Rego EM, et al
    Modeling dynamics and alternative treatment strategies in acute promyelocytic leukemia.
    PLoS One. 2019;14:e0221011.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: